Izraēla - angļu - Ministry of Health

roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.

Izraēla - angļu - Ministry of Health

roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.

Izraēla - angļu - Ministry of Health

roche pharmaceuticals (israel) ltd - oseltamivir as phosphate - capsules - oseltamivir as phosphate 30 mg - oseltamivir - treatment of influenza : treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. prophylaxis of influenza : post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. the appropriate use of tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. in exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older.משטר מינון 10/2/2019

Izraēla - angļu - Ministry of Health

roche pharmaceuticals (israel) ltd - oseltamivir as phosphate - capsules - oseltamivir as phosphate 45 mg - oseltamivir - treatment of influenza : treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. prophylaxis of influenza : post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. the appropriate use of tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. in exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 64379 - endoscope calibration cover, reusable - a cap/cover intended to be placed on the endoscope tip to allow alignment and calibration of the camera.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

taw pharma (ireland) ltd - pseudoephedrine hydrochloride - tablet - 60 milligram(s) - sympathomimetics; pseudoephedrine

Īrija - angļu - HPRA (Health Products Regulatory Authority)

taw pharma (ireland) ltd - loperamide hydrochloride - capsule, hard - 2 milligram(s) - antipropulsives; loperamide

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - nimodipine, quantity: 10 mg - injection, intravenous infusion - excipient ingredients: citric acid; sodium citrate dihydrate; water for injections; ethanol; macrogol 400 - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm after subarachnoid haemorrhage following ruptured intracranial aneurysm, in patients who are in good neurological condition post-ictus, e.g., hunt and hess grades i-iii (see section 5.1 pharmacodynamic properties).

Dienvidāfrikas Republika - angļu - South African Health Products Regulatory Authority (SAHPRA)

mc pharma (pty) ltd - injection - see ingredients - each 0,5 ml dose contains sars-cov-2 vaccine(vero cell) inactivated 6,5 u

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - exametazime, quantity: 0.5 mg - injection, powder for - excipient ingredients: sodium chloride; stannous chloride dihydrate - for use in the preparation of technetium tc 99m exametazime for intravenous administration in specialised units for scintigraphic localisation of seizure foci in patients with temporal lobe epilepsy.